Vyndaqel 20 mg Oral Capsule
RxNorm 2168548
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2168548 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Vyndaqel 20 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Tafamidis meglumine 20 mg Oral Capsule [Vyndaqel]
(Atom ID: 12362849)
SYPrescribable
Synonym (SY):
Vyndaqel 20 mg (equivalent to tafamidis 12.2 mg) Oral Tablet
(Atom ID: 11417156)
PSNPrescribable
Prescribable Name (PSN):
Vyndaqel 20 mg Oral Capsule
(Atom ID: 11417150)
SYPrescribable